Chart validation of an algorithm for identifying hereditary progressive muscular dystrophy in healthcare claims
Abstract Background Muscular dystrophies (MDs) are a group of inherited conditions characterized by progressive muscle degeneration and weakness. The rarity and heterogeneity of the population with MD have hindered therapeutic developments as well as epidemiological and health outcomes research. The...
Main Authors: | Xiaoxue Chen, Abiy Agiro, Ann S. Martin, Ann M. Lucas, Kevin Haynes |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | BMC Medical Research Methodology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12874-019-0816-7 |
Similar Items
-
Duchenne muscular dystrophy: an historical treatment review
by: Lineu Cesar Werneck, et al. -
Diagnosis of Congenital Muscular Dystrophy
by: J Gordon Millichap
Published: (1996-04-01) -
Strengthen the research of Duchenne muscular dystrophy in China
by: Cheng ZHANG
Published: (2015-06-01) -
Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
by: Michael Ogundele, et al.
Published: (2021-08-01) -
Duchenne and Becker muscular dystrophy: implications for at-risk individuals
by: Erasmus, Suretha
Published: (2010)